Genome-wide Screening of the Escherichia coli Keio Knockout Collection Identifies Genetic Determinants of Epetraborole Hypersusceptibility
European Journal of Clinical Microbiology & Infectious Diseases · 2025
DOI: 10.1007/s10096-025-05183-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2025. Verfasst von Anara Babayeva und 1 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Natural and Applied Sciences, Department of Biology, Muğla Sıtkı Koçman University, Muğla, Turkey. Hauptthemen laut MEDLINE: Escherichia coli, Anti-Bacterial Agents, Boron Compounds. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mugla Sitki KocmanUniversity.
Abstract (Originalsprache)
Purpose
The escalating threat of antibiotic resistance necessitates innovative strategies to enhance the efficacy of emerging antimicrobials. Epetraborole (EP) is a boron-containing antibiotic targeting leucyl-tRNA synthetase (LeuRS) and has attracted interest for its novel mechanism of action and potential to treat infections caused by multidrug-resistant (MDR) Gram-negative pathogens.
Methods
To elucidate the genetic determinants of EP susceptibility, we conducted a genome-wide screen (GWS) of the Escherichia coli Keio knockout collection, which comprises ~4,000 single-gene deletion mutants. Mutants exhibiting increased susceptibility to epetraborole were identified and validated via complementation assays.
Results
Disrupted genes included those involved in leucine biosynthesis ( leuD ), RNA turnover ( rnb ), tRNA modification ( trmU ), ubiquinone biosynthesis ( ubiG ), NAD salvage pathway ( pncA ), arginine transport ( artJ ), transcriptional regulator ( yddM ) and ribosome biogenesis ( yhbY ), suggesting that epetraborole’s primary inhibition of LeuRS synergizes with defects in these pathways. Bioinformatic analyses (Omics Dashboard, DAVID, STRING) linked these genes to tRNA homeostasis, stress response networks, and central dogma processes, implicating tRNA dysregulation as a critical vulnerability under epetraborole-induced stress.
Conclusion
This study identifies novel genetic contributors to epetraborole susceptibility and provides a framework for exploring adjuvant therapies or resistance mechanisms to enhance its clinical utility against MDR infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Natural and Applied Sciences, Department of Biology, Muğla Sıtkı Koçman University, Muğla, Turkey.
- College of Sciences, Department of Biology, Division of Biotechnology, Muğla Sıtkı Koçman University, Muğla, Turkey. bcol@mu.edu.tr.
- Biotechnology Research Center, Muğla Sıtkı Koçman University, Muğla, Turkey. bcol@mu.edu.tr.
Förderung
- Mugla Sitki KocmanUniversity
Zitieren
APA
Babayeva, A., & Çöl, B. (2025). Genome-wide Screening of the Escherichia coli Keio Knockout Collection Identifies Genetic Determinants of Epetraborole Hypersusceptibility. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-025-05183-9
Vancouver
Babayeva A, Çöl B. Genome-wide Screening of the Escherichia coli Keio Knockout Collection Identifies Genetic Determinants of Epetraborole Hypersusceptibility. European Journal of Clinical Microbiology & Infectious Diseases. 2025. doi:10.1007/s10096-025-05183-9
BibTeX
@article{Babayeva2025,
author = {Babayeva, Anara and Çöl, Bekir},
title = {Genome-wide Screening of the Escherichia coli Keio Knockout Collection Identifies Genetic Determinants of Epetraborole Hypersusceptibility},
journal = {European Journal of Clinical Microbiology & Infectious Diseases},
year = {2025},
doi = {10.1007/s10096-025-05183-9}
}
EUVIMED